Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Linear Diagnostics Limited logo — Linear Diagnostics utilises Linear Dichroism as a platform t...

Linear Diagnostics Limited

Linear Diagnostics utilises Linear Dichroism as a platform to develop point of care tests for infectious diseases.

Founded 2011 United Kingdom Birmingham, United Kingdom 6 employees Grant Total: $3.10M Biotechnology, Health Care

General Information

Company Name Linear Diagnostics Limited
Founded Year 2011
Location United Kingdom Birmingham, United Kingdom +1
Founders / Decision Makers
Alan Boyd FRSB FFLM FRCP FFPM FMedSci — Non-Executive Director
Employees 6
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when Linear Diagnostics Limited moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Linear Diagnostics Limited

Linear Diagnostics Limited (LDL) is a United Kingdom based biotechnology and healthcare startup founded in 2011. Utilizing Linear Dichroism as a platform, LDL develops point-of-care tests for infectious diseases. The company's technology offers a novel approach to molecular diagnostics, enabling a wide range of tests to be conducted using a simple optical system. This innovative method provides several advantages over the current state of the art, allowing for the rapid detection of multiple targets with a single reagent. LDL's solution has applications across various high-value sectors, including health, food, defense, and security. LDL has forged strategic partnerships with end users such as clinical microbiology, food producers, and defense medicine, demonstrating the broad applicability of its technology. The company recently received a grant investment on 08 June 2023 from the National Institute for Health Research, a notable achievement that underscores the recognition and support for the innovative diagnostic solutions being developed by Linear Diagnostics Limited.

Taxonomy: point of care tests, infectious diseases, molecular diagnostics, optical system, rapid detection, clinical microbiology, food producers, defence medicine, linear dichroism, diagnostics company, novel technology, health sector, food sector, defence and security sector

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Unknown 1 National Institute for Health Research 08 Jun 2023
Venture Round £800.00K 5
UK Innovation & Science Seed Fund Future Planet Capital Midlands Engine Investment Fund
The Future Fund, University of Birmingham 		24 Feb 2021
Venture Round £2.00M 2
Future Planet Capital Midlands Engine Investment Fund
08 Nov 2019
Seed Round £300.00K 2
UK Innovation & Science Seed Fund Future Planet Capital
24 May 2017

Linear Diagnostics Limited Alternatives & Competitors

Linear Diagnostics Limited vs
Science Group
Science Group United Kingdom

Science Group is an international, science-led services and product development organisation.

50 employees
Biotechnology
Linear Diagnostics Limited vs
Cignpost Diagnostics
Cignpost Diagnostics United Kingdom

Empowering people towards living healthier lives

139 employees
Health Care
Linear Diagnostics Limited vs
CONGEN Biotechnologie GmbH
CONGEN Biotechnologie GmbH Germany

Your partner in molecular diagnostics

17 employees
Biotechnology, Health Care

FAQ About Linear Diagnostics Limited

Linear Diagnostics utilises Linear Dichroism as a platform to develop point of care tests for infectious diseases.
Linear Diagnostics Limited was founded in 2011.
Linear Diagnostics Limited is headquartered in Birmingham, United Kingdom.
Linear Diagnostics Limited operates in the following industries: Biotechnology, Health Care.
Linear Diagnostics Limited has approximately 6 employees.
Linear Diagnostics Limited has completed 4 funding rounds, raising a total of $3.10M. The latest funding stage is Grant.
Top alternatives and competitors to Linear Diagnostics Limited include Science Group, Cignpost Diagnostics, CONGEN Biotechnologie GmbH, PAC Partners, Sumac Precision Engineering Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Linear Diagnostics Limited and Science Group are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Linear Diagnostics Limited and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy